CSIMarket
 
Maravai Lifesciences Holdings Inc   (NASDAQ: MRVI)
 

Maravai Lifesciences Holdings Inc's Suppliers Performance

MRVI's Supply Chain




 
MRVI Costs vs Sales of Suppliers Growth Maravai Lifesciences Holdings Inc's cost of sales deteriorated by -22.3 % year on year, relative to one quarter ago cost of sales fell by -3.77 % in Q2.

• More on MRVI Suppliers



Maravai Lifesciences Holdings Inc's cost of sales deteriorated by -22.3 % year on year, compare to one quarter ago cost of sales fell by -3.77 % in Q2.

• More on MRVI Suppliers




Maravai Lifesciences Holdings Inc's Comment on Supply Chain


The company sources raw materials such as nucleoside triphosphates (NTPs), enzymes, and proprietary technologies including ModTail™ and CleanCap® to support mRNA synthesis. It manufactures NTPs in both RUO and GMP grades, available as unmodified or modified for specific applications. The company utilizes enzymes, including a proprietary T7 enzyme, in nucleic acid production, which are integrated into the CleanScript™ mRNA production workflow. Additionally, it provides custom nucleotide chemistry synthesis and manufacturing services for mRNA, encompassing GMP mRNA synthesis and early-stage development services.

Maravai Lifesciences Holdings Inc's Comment on Supply Chain


The company sources raw materials such as nucleoside triphosphates (NTPs), enzymes, and proprietary technologies including ModTail™ and CleanCap® to support mRNA synthesis. It manufactures NTPs in both RUO and GMP grades, available as unmodified or modified for specific applications. The company utilizes enzymes, including a proprietary T7 enzyme, in nucleic acid production, which are integrated into the CleanScript™ mRNA production workflow. Additionally, it provides custom nucleotide chemistry synthesis and manufacturing services for mRNA, encompassing GMP mRNA synthesis and early-stage development services.







MRVI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Maravai Lifesciences Holdings Inc 1,124.77 207.89 -136.08 435
SUBTOTAL 0.00 0.00 0.00 -


Sources: Maravai Lifesciences Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Maravai Lifesciences Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.